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Abstract
AIM: To assess the mucosa-associated bacterial 
microflora and mucus layer in adolescents with 
inflammatory bowel disease (IBD).
METHODS: Sixty-one adolescents (mean age 15 years, 
SD ± 4.13) were included in the study. Intestinal 
biopsies from inflamed and non-inflamed mucosa of IBD 
patients and from controls with functional abdominal 
pain were cultured under aerobic and anaerobic 
conditions. The number of microbes belonging to the 
same group was calculated per weight of collected 
tissue. The mucus thickness in frozen samples was 
measured under a fluorescent microscope.
RESULTS: The ratios of different bacterial groups in 
inflamed and non-inflamed mucosa of IBD patients 
and controls were specific for particular diseases. 
Streptococcus spp . were predominant in the inflamed 
mucosa of Crohn’s disease (CD) patients (80% of all 
bacteria), and Lactobacillus spp . were predominant in 
ulcerative colitis patients (90%). The differences were 
statistically significant (P = 0.01-0.001). Lower number 
of bifidobacteria was observed in the whole IBD group. A 
relation was also found between clinical and endoscopic 
severity and decreased numbers of Lactobacillus  and, 
to a lesser extent, of Streptococcus in biopsies from 
CD patients. The mucus layer in the inflamed sites was 
significantly thinner as compared to controls (P = 0.0033) 
and to non-inflamed areas in IBD patients (P = 0.031).
CONCLUSION: The significantly thinner mucosa of 
IBD patients showed a predominance of some aerobes 
specific for particular diseases, their numbers decreased 
in relation to higher clinical and endoscopic activity of 
the disease.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
The term inflammatory bowel disease (IBD), used to 
describe the chronic intestinal processes, includes ulcerative 
colitis (UC) and Crohn’s disease (CD). Despite very 
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extensive studies, the pathogenesis of  IBD still remains 
unclear. Genetic, environmental and immunological 
factors seem to play a substantial role[1]. However, an 
increasing number of  both clinical and laboratory 
studies support the idea of  the leading role of  bacterial 
microflora in the onset and persistence of  inflammation[2]. 
It is well known that the anatomic sites with the highest 
concentration of  luminal bacteria are most often involved 
in the inflammatory process[3]. Giaffer et al[4] showed in 
1991 that intestinal flora of  patients with active CD is 
different from that of  quiescent patients, UC subjects 
and controls with functional abdominal pain. Patients 
with Crohn’s disease presented with elevated numbers of  
aerobic bacteria, mainly Escherichia coli, and some anaerobic 
bacteria. There was also evidence of  decreased numbers 
of  Bifidobacteria. The results of  research based on animal 
models support the importance of  luminal bacteria in 
experimental colitis. Transgenic mice kept under germ 
free conditions did not develop inflammation until 
bacteria were introduced[5]. In recent years, the results of  
several reviews on gut microflora and IBD have suggested 
that inflammation may be due to a shift in the balance 
of  healthy flora, which leads to dysregulation of  the 
microflora and triggers or maintains the inflammation[6,7]. 
Moreover, it is also known, that microbes which were 
in close contact with the epithelium were different from 
those found in stools, and probably more important in the 
process of  gut inflammation[8].
There is very little information about the specificity 
of  the gut microbiota in adolescents with IBD. Up to 
now, only one study in the literature by Conte et al[9] 
where both culture and PCR amplification methods 
were used, found higher numbers of  mucosa-associated 
bacteria in biopsies from IBD children in comparison 
to controls. On the other hand, the occurrence of  strict 
anaerobes including Bacteroides was low in specimens 
from patients with CD, UC and indeterminate colitis.
It has also been demonstrated that mucus which 
is an integral part of  the mucosal barrier may play an 
important role in hindering penetration of  the mucosa by 
luminal bacteria and their products thus preventing the 
inflammatory process. A study by Pullan et al[10] showed 
that a reduction of  mucus layer thickness in adult IBD 
patients caused increased exposure of  the microbes to 
the gut immune system, which in turn sustained the 
inflammation.
Both mucus and mucosa-associated bacterial microflora 
form a specific environment in the gut and its disruption 
may play a crucial role in the development of  IBD, 
promoting specific bacterial colonization and immunolo-
gical response.
Assessment of  the multiple interactions among 
bacterial microflora and mucus in the very early stage of  
IBD, seen in newly diagnosed disease, is essential for a 
better understanding of  disease pathogenesis and may 
help in suggesting therapeutic options such as the use of  
specific probiotics or antimicrobial treatment.
The aim of  our study was to assess mucosa-associated 
bacterial microflora and mucus layer thickness in relation 
to the inflammatory process in adolescents with IBD in 
comparison to controls.
MATERIALS AND METHODS
Ethics
The trial was approved by the Jagiellonian University 
Bioethical Committee and informed consent was obtained 
from all patients’ legal guardians and/or patients over 
16 years of  age enrolled in the study.
Patients
Sixty-one adolescents (25 boys and 36 girls, age: 15 ± 4.13 
years) were enrolled in the study from January 2004 to 
October 2006. There were 12 patients with UC (5 boys 
and 7 girls, age: 14.74 ± 2.9 years), 22 with CD (9 boys 
and 13 girls, age: 16.22 ± 3.8 years) and 3 with indetermi-
nate colitis (IC) (1 boy and 2 girls, age: 15.01 ± 7.9 years) 
in the study group and 24 control subjects (10 boys, 14 
girls, age: 14.13 ± 4.4 years) who underwent colonoscopy 
because of  chronic abdominal pain, which was finally 
diagnosed as functional abdominal pain, without any or-
ganic abnormalities. The mean duration of  symptoms in 
the UC group was 96.5 ± 75.1 d, 153 ± 146.7 d in the CD 
group and 40.5 ± 27.6 d in the IC group. IC patients were 
not considered for further analysis as a separate group due 
to the small number of  subjects. Patients with UC were 
younger at disease onset (11.64 ± 4.44 years) than those 
with CD (13.67 ± 3.28 years). Nutritional status of  the 
patients assessed according to the Cole index was com-
parable in both groups (UC group - 84.57, CD - 82.89). 
Abdominal pain as the main complaint was more frequent 
in the group with CD (85.7%) than UC (81.1%), whereas 
bloody diarrhea and sideropenic anemia were more fre-
quent in UC (81.2% and 36.4%, respectively) than CD 
patients (40.9% and 19.1%, respectively). Only 9% of  UC 
patients presented with fever at disease onset, as com-
pared to 27.2% of  CD patients.
The diagnosis of  CD or UC was based on endoscopic, 
histopathological, immunological and radiological criteria. 
Disease activity was assessed according to the Pediatric 
Crohn’s Disease Activity Index (PCDAI) for CD patients 
and the modified Trulove-Witts score for UC patients[11]. 
Depending on the score value the patients were classified 
into three subgroups of  disease activity: mild, moderate 
and severe. The majority of  patients in both groups were 
classified as having mild (UC - 4 and CD - 8) to moderate 
(UC - 8 and CD - 12) stages of  clinical activity. Only 2 
patients with CD (and none with UC) were classified 
as having severe clinical activity. For the evaluation of  
endoscopic changes we used Roth’s score[12]. Seven UC 
patients showed severe endoscopic activity compared 
to 6 patients with CD. A minority of  patients in the UC 
group showed mild (2 children) to moderate (3 patients) 
endoscopic activity, as compared to the CD group (7 and 
6 patients, respectively). Histology was assessed blindly by 
an independent histopathologist. All patients with IBD 
were in the active phase of  the disease.
The use of  antibiotics 30 d prior to enrolment, 
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infectious diarrhea, malabsorption, immunodeficiencies 
and intestinal enteropathies were the exclusion criteria.
Sampling of mucosa
All subjects underwent the same type of  preparation 
prior to colonoscopy, with oral sodium phosphate at a 
dose of  0.6-0.8 mL/kg (up to 45 mL) and bowel cleans-
ing, consisting of  4 saline enemas. During colonoscopy, 
patients received intravenous sedation or general anes-
thesia, as required. Biopsy samples from IBD patients 
were obtained from both, the inflamed and the non-
inflamed colonic mucosa. Four biopsy specimens were 
taken from both sites: two for culture, and one each for 
standard histopathological assessment and mucus thick-
ness measurement. In the control group, the biopsy 
samples were taken from a normal sigmoid colon for the 
same assessments. The biopsy samples were transferred 
directly into Schaedler Anaerobic Broth (SAB) medium 
(Difco, BD, Franklin Lakes, USA) with 10% of  glycerol. 
The samples were immediately snap frozen on dry ice 
and kept at -80℃ or on dry ice until analysis. All proce-
dures were performed as fast as possible, using sterile 
instruments and ensuring the integrity of  the intestinal 
tissue. The codes of  the biopsy samples were blinded 
before performing microbiological analysis.
Bacteriology
The frozen samples were thawed, weighed, homogenized 
in 1 mL of  SAB and quantitatively analyzed for the main 
bacterial constituents by cultures on differential media 
in aerobic and anaerobic conditions[9]. All these manipu-
lations were done aseptically in an anaerobic chamber 
(MACS - MG 500 Work Station, DW Scientific, Shipley, 
UK) in N (85%) + H2 (10%) + CO2 (5%) atmosphere. 
Homogenized samples were serially diluted with SAB and 
100 µL aliquots plated on the following media: McCon-
key Agar (Oxoid, Basingstoke, UK) for Enterobacteriaceae, 
Columbia Blood Agar (Difco) with 5% sheep blood for 
streptococci, Enterococcosel Agar (BBL, BD, Franklin 
Lakes, USA) for enterococci, MRS agar (Oxoid) for lac-
tobacilli and other lactic acid bacteria (LAB), BL agar for 
bifidobacteria[13], and Wilkins-Chalgren Agar Base with 
supplements for Bacteroides.
The dilutions were then spread over the plate surface 
using a glass rod and the plates were then incubated 
aerobically at 37℃ for 24 h, except for the cultures for 
anaerobic bacteria, which were kept in the anaerobic 
chamber for up to 4 d depending on the type of  medium. 
The morphology of  the grown colonies was analyzed 
under magnifying glass and several colony picks of  each 
morphological type were subcultured on appropriate 
aerobic and anaerobic media and Gram-stained. After 
further incubation and culture purity checks, phenotypic 
identification was performed using commercial identifi-
cation systems (API 20E, API20A, APIStaph, APIStrept, 
bioMerieux, Marcy l'Etoile, France; BBL Crystal ID System, 
BD, Franklin Lakes, USA).
Measurement of the mucus layer thickness
The frozen biopsy samples, collected as described 
above, were cut into 5 µm sections, thawed and fixed to 
microscopic slides and stained with fluorescein labeled 
Maackia amurensis lectin MAA lectin (EY Labs, San Mateo, 
USA) which binds to 2-3 linked sialic acid[14]. Briefly, the 
lectin solution (20 µg/mL in 0.05% sodium azide solution 
in a buffer supplied by the producer) was applied in a 
50 µL volume to each slide and incubated under cover 
in a dark moist chamber at room temperature for 0.5 h. 
Then the unbound lectin was washed out with the buffer 
and the slides were counterstained with DAPI (Sigma, 
St. Louis, USA), washed again and dried. The mucus 
thickness was measured under a fluorescent microscope 
(Olympus BX51) with 100 × magnification.
Statistical analysis
Comparisons were made using the Student’s t test for vari-
ables with a normal distribution and χ2 test. For compari-
son of  bacterial populations and ratios of  particular bac-
terial groups the likelihood ratio was used. The Wilcoxon 
test and Wilcoxon signed-rank test for matching pairs 
were used to compare mucus thickness. These statistical 
methods were chosen because data distribution was sig-
nificantly different from normal distribution. All analyses 
were conducted using SAS 9.1 package and SAS Enter-
prise Quide 3.0 (SAS Institute, USA). Data are expressed 
as mean ± SD.
RESULTS
All biopsy specimens from IBD patients and controls 
showed the presence of  all groups of  bacteria in the 
cultures although of  different populations. The total 
number of  mucosa-associated bacteria was higher in 
IBD patients compared to the controls with functional 
abdominal pain, however, the differences were statistically 
significant only in the UC group. Because of  high 
diversities among the isolated bacteria and their numbers, 
the ratios of  bacterial groups present were calculated as 
pooled numbers of  bacteria weighted by the number of  
patients in the groups (Table 1).
The ratios of  different bacterial groups cultured from 
biopsies obtained both from inflamed and non-inflamed 
sites in IBD patients were different in samples taken 
from children with specific diseases. The differences 
were statistically significant (χ2 test, P < 0.0001). Strepto-
cocci were the predominant group of  bacteria in inflamed 
mucosa of  CD patients. About 80% of  all microbiota 
cultured from the tissue belonged to these genera. On 
the other hand, patients with UC showed predominance 
of  Lactobacillus (90%) in inflamed sites (Table 1). Both 
CD and UC patients showed a significant reduction in 
the ratios for anaerobes such as Bifidobacterium in samples 
taken from inflamed compared to non-inflamed mucosa. 
Considering the ratios of  bacteria found in non-inflamed 
mucosa of  IBD patients as compared with those found 
in controls, it appeared that bifidobacteria were the pre-
dominant group in all these sites (Table 1).
We also looked at the relationship between the total 
numbers of  bacteria and disease activity, measured using 
PCDAI for CD patients and the modified Trulove-Witts 
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score for UC in addition to the Roth’s endoscopic scor-
ing index. To express these relationships we adopted the 
five interval scale of  bacterial populations from Swid-
sinski et al[15]: 0-103 cfu/g, 103-104 cfu/g, 104-105 cfu/g, 
105-107 cfu/g, and > 107 cfu/g.
The total numbers of  cultured bacteria found in biop-
sies from inflamed mucosa of  UC patients was increased 
with severity of  the disease estimated by endoscopic ac-
tivity (Figure 1). This relationship was statistically signifi-
cant (likelihood ratio = 9.535, P = 0.0490). In relation to 
specific groups of  bacteria, this analysis showed that the 
number of  lactobacilli, which was the predominant group 
in the samples from inflamed mucosa of  patients with 
UC, was lower in samples taken from patients with severe 
endoscopic activity. This was, however, not statistically 
significant (likelihood ratio = 6.959, P = 0.1381). 
There was no relationship between the total numbers 
of  bacteria in samples from inflamed sites and sever-
ity of  the disease in CD patients. In relation to various 
groups of  bacteria, the analysis showed that numbers 
of  lactobacilli were lower in samples with higher clinical 
activity (likelihood ratio = 13.209, P = 0.0328, Figure 2). 
The same tendency, although less significant, was ob-
served for numbers of  streptococci in samples from CD 
patients (likelihood ratio = 13.889, P = 0.0847).
When studying the thickness of  the mucus layer in 
biopsies taken from inflamed sites of  the gut in adoles-
cents with IBD, it appeared thinner when compared to 
the controls (CD-74 ± 40 µm; UC-83.35 ± 49.93 µm; 
controls- 218 ± 81.07 µm) and these differences were 
statistically significant (P = 0.0047 and P = 0.0093, re-
spectively) (Figure 3). Also, the matching pair test analy-
sis showed a statistically significant thinner mucus layer 
in inflamed as compared to non-inflamed sites in the 
same IBD patients (Z = 10.50, P = 0.031). Focusing on 
specific IBD groups and comparing inflamed to non-
inflamed sites, the difference was significant in CD (P 
= 0.0109), but not in UC patients (P = 0.0662). On the 
other hand, there was no difference between the CD 
and control group (P = 0.7003) and the UC and control 
Table 1  Median number of isolated bacteria per gram in different groups from inflamed and non inflamed tissue taken from children 
with CD, UC and from the control group
Bacterial groups (taxons) Children with UC (n  =12) Children with CD (n  = 22) Children in control group 
(n  = 24)
Inflamed site Non-inflamed Inflamed site Non-inflamed
Enterobacteriacae 4.92 × 105 5.55 × 106 2.17 × 107 9.71 × 106 1.94 × 107
Enterococcus 1.80 × 106 1.27 × 106 1.36 × 106 1.43 × 106 6.82 × 105
Streptococcus 6.83 × 105 1.07 × 106   1.29 × 108b 1.33 × 106 5.39 × 106
Lactobacillus   9.28 × 107a 7.30 × 106 3.37 × 106 7.76 × 106 1.01 × 107
Bifidobacterium   5.56 × 106a 7.14 × 107   8.62 × 106a 3.15 × 107 1.99 × 108
Bacteroides 1.63 × 106 5.13 × 102 1.24 × 105 2.31 × 105 1.63 × 106
Total number of cultured bacteria   5.83 × 108a 4.79 × 108 3.93 × 108 2.30 × 108 1.77 × 108
aP < 0.05, bP < 0.01 differences between inflamed site and the control group; CD: Crohn’s disease; UC: Ulcerative colitis.
103-104
104-105
105-107
> 107
Figure 1  Relationships between endoscopic activity and total numbers of bacteria cultured from biopsies of UC patients and the control group. Likelihood 
ratio = 9.535, P = 0.0490. UC: Ulcerative colitis.
Control Mild Moderate Severe
0-103
103-104
104-105
105-107
> 107
Control Mild Moderate Severe
Figure 2  Relationships between disease activity and numbers of Lactobacillus group of bacteria cultured from biopsies of CD patients and the control 
group. Likelihood ratio = 13.209, P = 0.0398. CD: Crohn’s disease.
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group (P = 0.3137) (Figure 4) when comparing the thick-
ness of  the mucus layer in biopsies from non-inflamed 
areas in IBD patients to those of  the control group.
When trying to assess the histopathological activity 
and goblet cell depletion according to the scoring index 
proposed by Kudo et al[16], we found no statistically signifi-
cant differences between thinner and thicker mucus layer 
sites both in the UC and CD groups. However, histopath-
ological activity and goblet cell depletion was more severe 
in the UC group (77% and 61.5%, respectively) than in 
the CD group (59.1% and 32%, respectively). 
Considering the numbers of  bacteria contained in 
the biopsy samples, their ratios and the mucus thickness 
no relationship was found between age, gender and dis-
ease status of  the patients.
DISCUSSION
It is well known that bacterial microflora in the human 
gastrointestinal tract play an important role in maintaining 
human health and may also contribute to the pathogenesis 
of  IBD[17]. The data from animal models of  IBD suggest 
that intestinal inflammation is dependent on the presence 
of  intestinal microflora, although no specific pathogen 
has been identified and confirmed to be responsible for 
this process. Some studies performed on adult patients 
showed a strong correlation between disease activity and 
increased numbers of  bacteria attached to the mucosa[18,19]. 
Although in our study we did not observe a significant 
increase in microflora contained in the biopsy samples 
in IBD adolescents in relation to controls, we did find 
a higher number of  bacteria in biopsies taken from UC 
patients, particularly in those with the most advanced stage 
of  changes as estimated at endoscopy. Increasing disease 
activity was inversely related to the numbers of  lactobacilli 
in samples from CD (but not from UC patients) and to a 
minor degree to Streptococcus.
In various studies carried out on adult IBD patients, 
it is possible to find conflicting results relating to the 
numbers of  specific groups or genera of  bacteria with 
respect to inflammation. Some authors reported increased 
numbers of  aerobic Gram-negative rods (E. coli), while 
others found increased numbers of  non-spore forming 
anaerobes (Proteobacteria and Bacteroides) and decreased 
numbers of  spore-forming anaerobes like Clostridium[20-24]. 
There are also papers in which the authors found no 
differences between the bacterial flora in inflamed and 
non-inflamed tissue in the same patient[25,26]. On the 
contrary, Sepehri et al[27] using a PCR method showed 
significant differences in bacterial flora between the 
inflamed and non-inflamed mucosa, and an increase in 
microbial diversity in controls and the non-inflamed tissue 
from adult IBD patients. 
We found differences in microflora composition 
between endoscopically inflamed and non-inflamed 
mucosal sites in newly diagnosed IBD adolescents which 
were specific for each form of  the disease. In the controls 
and in the endoscopically non-inflamed mucosa of  IBD 
children there were high numbers of  bifidobacteria 
compared with decreased populations of  these bacteria in 
inflamed sites of  IBD patients. Thus, our observations are 
in concordance with the earlier findings of  Seksik et al[28] 
who also showed decreased numbers of  Bifidobacterium 
and Enterobacteriaceae in adult patients with active and 
inactive CD. Our CD and UC patients also had decreased 
numbers of  Bifidobacterium in inflamed mucosal sites 
compared with controls. It should also be noted that the 
numbers of  lactobacilli, known for their protective effect 
in IBD, were lower in samples from CD adolescents with 
severe inflammation in our study[29]. Seksik et al[28] showed 
that the numbers of  Lactobacillus strains were low in active 
and inactive CD adult patients.
Conte et al[9] recently reported the first, to our knowl-
edge, study on gut-associated bacterial microflora in chil-
dren with IBD. They found higher numbers of  aerobic 
and facultative anaerobic bacteria in biopsy specimens 
from IBD children in comparison to controls, but lower 
numbers of  Bacteroides in CD patients. 
It should be noted that more than 50% of  intestinal 
bacteria are not cultivable and this may represent a limi-
tation of  the study. Furthermore, molecular analytical 
methods have utility in discriminating between bowel 
microbiota of  altered compositions and could be used in 
future studies in children. These techniques enable char-
acterization as well as quantification of  the microbiota; 
composition of  the microbiota may be identified with 
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Figure 3  The average thickness of the mucus layer in biopsy samples 
obtained from inflamed areas in CD (H = 8.0, P = 0.0047) and UC (H = 6.76, 
P = 0.0093) patients and controls. The horizontal line represents median 
value with 25% and 75% quartile.
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Figure 4  The average thickness of the mucus layer in biopsy samples 
obtained from non-inflamed areas in CD (H = 0.1481, P = 0.7003) and UC 
(H = 0.987, P = 0.3137) patients and controls. The horizontal line represents 
median value with 25% and 75% quartile.
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clone libraries, fingerprinting techniques may be used to 
analyze microbial community structure and dot blot hy-
bridization or fluorescent in situ hybridization (FISH) may 
be used to analyze a multitude of  given taxa[30-32]. In our 
previous pilot study (results not included here) we used 
FISH to analyze colonic microflora in children with IBD, 
however, this approach was limited by low sensitivity of  
the method.
Considering the conflicting results on microflora in 
IBD presented in the literature one should remember 
that the patient populations as well as stages of  the 
illness in various studies were different. Other factors 
that could strongly affect the results and cause obvious 
discrepancies were: different sites from which the 
biopsies were taken, the cleaning procedures and 
microbiological methods used to identify the microflora. 
Moreover, it is possible that gut bacterial flora in children 
is generally less stable than in adults. All these factors 
could be responsible for the observed variations.
We have carried out our investigation using samples 
of  tissue and feces which were stored at -80℃ during 
transport from the ward to the laboratory. According to 
Achá et al[33] and Dan et al[34], freezing does not influence 
viability of  fecal samples.
Colonic mucus is an adherent, water insoluble gel 
that has several functions, including protection of  the 
epithelium from mechanical trauma, toxins, allergens 
and from microbial invasion[35]. Thus, the mucus layer 
plays a protective role in the intestinal mucosa[36,37]. 
The gut mucus lubricates the passage of  food and 
protects the epithelial cells from direct contact with 
bacterial flora. The mucus consists of  glycoproteins 
called mucins, which are encoded by many MUC genes - 
to date more than 20 types of  MUC genes have been 
described[38]. Thickness of  the mucus layer is related 
to the dynamic equilibrium between mucus secretion 
and its subsequent removal into the lumen. In UC, the 
absence of  an adherent layer in some areas may be a 
result of  inadequate secretion or excessive removal. The 
findings of  various studies on mucus synthesis in colitis 
have suggested that the epithelial layer remains intact in 
the presence of  mild to moderate inflammation. In the 
presence of  severe inflammation or inactivity, however, 
it tends to be lower than normal[10].
In our study we have shown that the thickness of  the 
mucus layer lining the intestinal lumen of  adolescents 
with IBD is about three times thinner in both CD 
and UC patients compared with the control group. 
A similar relationship was observed in biopsies taken 
from inflamed and non-inflamed mucosa in the same 
IBD patients and these differences were statistically 
significant. In addition, we have demonstrated that 
mucus layer thickness measured in tissue samples taken 
from normal sites in patients with IBD was only slightly 
thinner than that in the control group and the difference 
was not statistically significant.
 At present, there is no data in the literature on the 
mucus layer in children and adolescents with CD. There 
is also no clear explanation of  observed differences, 
however, the results of  the latest studies are in accordance 
with our findings. The course of  CD and localization 
of  inflammatory lesions in childhood may be quite 
different from than in adults. The majority of  CD 
adolescents (63.6%) in our study had colon involvement 
on endoscopic assessment, similar to UC which may have 
influenced the observed mucus layer depletion in this 
group of  patients. Moreover, Gersemann et al[39] using 
a real-time PCR method in adult IBD patients, showed 
that goblet cells were diminished in the intestinal biopsies 
of  both UC and CD patients, however, in the CD group 
enhanced differentiation was found. 
In addition, using immunostaining Ardesjö et al[40] 
reported the presence of  immunoreactive agents in the 
serum of  IBD patients, which reacted with goblet cells 
in the intestine. 
A reduction in mucus layer thickness leads to bacteria 
from the intestinal lumen having closer contact with the 
intestinal epithelium, also causing a different selection 
of  microorganisms, which may induce an inflammatory 
process in the bowel[10]. In adult patients suffering from 
IBD, the numbers of  bacterial cells adhering to the 
intestinal mucus layer are much higher as compared to 
controls without IBD, and this dependence is proportional 
to the severity of  the clinical course[19,21]. Whether this 
is a result or cause of  bowel inflammation still remains 
unclear, however, the protective property of  the mucosa is 
significantly weakened by this process.
In summary, our results showed that non-inflamed 
mucosa in both IBD patients and controls was covered 
with a thick mucus layer with the attached microflora 
showing a predominance of  Bifidobacterium. In contrast, 
in inflamed sites there was a reduction in mucus layer 
thickness with the prevalence of  specific bacterial groups 
which were different for CD and UC: Streptococcus in 
CD and Lactobacillus in UC. However, numbers of  these 
bacteria decreased proportionally with the intensity of  
inflammation. Thus, our results also support the idea of  a 
disruption of  the balance between the different protective 
and harmful intestinal bacteria in the gastrointestinal tract. 
These results also provide evidence which suggest that the 
therapeutic use of  probiotics, especially those containing 
Bifidobacterium and Lactobacillus may have some positive 
effects in patients with IBD.
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Background
The pathogenesis of inflammatory bowel disease (IBD) still remains unclear. 
Genetic, environmental and immunological factors seem to play a substantial 
role. However, an increasing number of both clinical and laboratory studies 
support the idea of the leading role of bacterial microflora in the onset and 
persistence of inflammation. It is well known, that the anatomic sites with 
the highest concentrations of luminal bacteria are most often involved in the 
inflammatory process. The intestinal flora of patients with active Crohn’s 
disease (CD) is different from that of quiescent subjects, ulcerative colitis (UC) 
patients and healthy controls. Transgenic mice kept under germ-free conditions 
did not develop inflammation until bacteria were introduced. In recent years 
several studies on gut microflora have suggested that inflammation may be due 
to a shift in the balance of healthy flora, which leads to dysbiosis and triggers or 
maintains inflammation. 
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in the children’s mucosa play a crucial role in IBD pathogenesis. We suggest 
that the local mucus layer in the intestine, especially in childhood, determines 
bacterial colonization and metabolism. The aim of our study was to assess 
mucosa-associated bacterial microflora and mucus layer thickness in relation 
to the inflammatory process in adolescents with newly diagnosed IBD in 
comparison to controls. 
Innovations and breakthroughs
Up to now, this is the second study focused on the mucosa-associated bacterial 
microflora in children with IBD, used both culture and a PCR amplification 
method, and found significant differences between CD and UC children. The 
authors went a step further and assessed both the mucosa-associated bacterial 
microflora and intestinal mucosa.
Applications
Assessment of the multiple interactions among bacterial microflora and mucus 
in the very early stage of IBD, seen in newly diagnosed disease, is essential 
for a better understanding of disease pathogenesis and may help in suggesting 
therapeutic options such as the use of specific probiotics or antimicrobial 
treatment.
Terminology
Mucosa-associated bacterial microflora consists of bacteria that are located very 
close to the mucus layer. This layer forms a specific environment in the gut and its 
disruption may play a crucial role in the development of IBD, promoting specific 
bacterial colonization and immunological response. The colonic mucus layer is 
an adherent, water insoluble gel that has several functions, including protection 
of the epithelium from mechanical trauma, toxins, allergens and from microbial 
invasion. The mucus consists of glycoproteins called mucins, which are encoded 
by many MUC genes - to date more than 20 types of MUC genes have been 
described. Thickness of the mucus layer is related to the dynamic equilibrium 
between mucus secretion and its subsequent removal into the lumen.
Peer review
The authors demonstrated changes of mucosa-associated microbiota in 
adolescents with IBD, using classical culture techniques. They also showed 
depletion of the mucus layer in IBD patients. This paper is well documented.
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